Oxford Nanopore Technologies (LON:ONT) Price Target Raised to GBX 225

Oxford Nanopore Technologies (LON:ONT) had its target price upped by Deutsche Bank Aktiengesellschaft from GBX 210 to GBX 225 in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also issued reports on ONT. Berenberg Bank reaffirmed a “buy” rating and set a GBX 250 target price on shares of Oxford Nanopore Technologies in a research report on Monday, January 12th. Royal Bank Of Canada upped their price objective on shares of Oxford Nanopore Technologies from GBX 280 to GBX 300 and gave the company an “outperform” rating in a report on Wednesday. Finally, Peel Hunt reiterated a “hold” rating and issued a GBX 153 target price on shares of Oxford Nanopore Technologies in a research note on Friday, December 5th. Four investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 233.60.

Oxford Nanopore Technologies Price Performance

Shares of ONT stock opened at GBX 168.98 on Thursday. Oxford Nanopore Technologies has a 52-week low of GBX 88.60 and a 52-week high of GBX 224.80. The firm has a market capitalization of £1.63 billion, a P/E ratio of -11.42 and a beta of 0.80. The company has a debt-to-equity ratio of 8.07, a quick ratio of 6.01 and a current ratio of 4.45. The stock has a 50 day moving average price of GBX 135.82 and a 200 day moving average price of GBX 156.34.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.